WFDC2 and atypical endometrial hyperplasia: Objective: To investigate whether serum human epididymis protein 4 (HE4) could identify concurrent intermediate-high-risk endometrial cancer (EC) in patients diagnosed with endometrial atypical hyperplasia before definitive surgery (preoperative-EAH).